Deltex Medical Group Plc Revenues Decline To £2.0 Million In H1 FY19

  • Deltex Medical Group Plc (DEMG) has announced its unaudited interim results for the six months ended 30 June 2019.
  • The company’s revenues in the reported period declined to £2.0 million from £2.3 million reported in H1 FY18.
  • The company reported 35 per cent reduction in overhead costs (excluding exceptional items) to £1.7 million as compared to £2.7 million in H1 FY18.
  • The loss for the reported period reduced to £0.3 million from a loss of £1.2 million reported in H1 FY18.
  • On 23rd September 2019, at the time of writing, GMT 08:09 AM, DEMG shares were trading at GBX 1.35, up by 0.025 points or 1.89% against the previous day closing price.